Access to anti-retroviral drugs, female in Canada
Canada: Access to anti-retroviral drugs, female was 72.0% in 2022. ▲ Rising
Access to anti-retroviral drugs, female in Canada, 2000–2022
Source: UNAIDS estimates. Measured in %.
Analysis
In 2022, access to anti-retroviral drugs, female in Canada stood at 72.0%.
Compared with earlier readings it is down 2.7% on the previous year and up 50.0% over ten years.
Over the whole period, access to anti-retroviral drugs, female in Canada peaked at 75.0% in 2018 and was at its lowest, 14.0%, in 2000.
That places Canada 76th out of 141 countries with data for 2022, putting it in the middle of the range.
The long-run direction has been consistently rising across the 23 years of available data.
Access to anti-retroviral drugs, female in Canada, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 14.0% | — |
| 2001 | 17.0% | +21.4% |
| 2002 | 21.0% | +23.5% |
| 2003 | 23.0% | +9.5% |
| 2004 | 25.0% | +8.7% |
| 2005 | 27.0% | +8.0% |
| 2006 | 29.0% | +7.4% |
| 2007 | 31.0% | +6.9% |
| 2008 | 32.0% | +3.2% |
| 2009 | 43.0% | +34.4% |
| 2010 | 44.0% | +2.3% |
| 2011 | 46.0% | +4.5% |
| 2012 | 48.0% | +4.3% |
| 2013 | 62.0% | +29.2% |
| 2014 | 65.0% | +4.8% |
| 2015 | 68.0% | +4.6% |
| 2016 | 70.0% | +2.9% |
| 2017 | 73.0% | +4.3% |
| 2018 | 75.0% | +2.7% |
| 2019 | 75.0% | +0.0% |
| 2020 | 75.0% | +0.0% |
| 2021 | 74.0% | -1.3% |
| 2022 | 72.0% | -2.7% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 26.2% | 14.0% | 43.0% | 10 |
| 2010s | 62.6% | 44.0% | 75.0% | 10 |
| 2020s | 73.7% | 72.0% | 75.0% | 3 |
Countries ranked near Canada
More gender data for Canada
- Child population (UN estimates and projections) 5,985 (2030)
- Child population (UN estimates and projections) (0-14), annual growth -0.1285 % change on previous year (2030)
- Population 35,670 (2030)
- Working-age population (UN estimates and projections) 35,670 (2030)
- Population (UN estimates and projections), annual growth rate 0.8111 % change on previous year (2030)
- Age population, age 00, female, interpolated 179,464 (2025)
- Age population, age 00, male, interpolated 188,972 (2025)
- Age population, age 01, female, interpolated 181,929 (2025)
- Age population, age 01, male, interpolated 191,273 (2025)
- Age population, age 02, female, interpolated 183,113 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, female in Canada?
- Access to anti-retroviral drugs, female in Canada was 72.0% in 2022, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in Canada?
- The highest recorded value was 75.0% in 2018.
- What is the lowest access to anti-retroviral drugs, female recorded in Canada?
- The lowest recorded value was 14.0% in 2000.
- How does Canada rank for access to anti-retroviral drugs, female?
- Canada ranks 76th out of 141 countries with data for 2022.
- Is access to anti-retroviral drugs, female rising or falling in Canada?
- Over the last ten years it is up 50.0%. The long-run trend across the full record is rising.
- Where does this Canada data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 23 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.